| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.20B | 32.23B | 33.77B | 28.57B | 26.84B | 27.30B |
| Gross Profit | 4.77B | 5.13B | 4.31B | 3.77B | 3.37B | 4.27B |
| EBITDA | 4.46B | 2.44B | 4.01B | 1.40B | 918.00M | 1.73B |
| Net Income | 2.50B | 993.00M | 2.19B | 415.00M | 123.00M | 775.00M |
Balance Sheet | ||||||
| Total Assets | 35.71B | 35.61B | 37.78B | 33.68B | 28.79B | 27.79B |
| Cash, Cash Equivalents and Short-Term Investments | 2.54B | 1.96B | 3.08B | 2.20B | 2.32B | 3.25B |
| Total Debt | 8.89B | 10.55B | 10.79B | 9.04B | 6.46B | 4.95B |
| Total Liabilities | 23.43B | 22.47B | 25.47B | 23.27B | 18.86B | 17.96B |
| Stockholders Equity | 12.27B | 13.14B | 12.31B | 10.41B | 9.93B | 9.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -598.00M | -4.03B | -2.51B | -2.21B | 2.32B |
| Operating Cash Flow | 0.00 | 418.00M | -2.33B | -1.09B | -1.16B | 3.15B |
| Investing Cash Flow | 0.00 | -1.09B | 1.70B | -1.46B | -1.10B | -1.08B |
| Financing Cash Flow | 0.00 | -464.00M | 1.51B | 2.42B | 1.33B | -287.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥12.02B | 7.91 | ― | 3.91% | 20.63% | -4.71% | |
73 Outperform | ¥7.32B | 5.49 | ― | 2.16% | 49.73% | 172.92% | |
70 Outperform | ¥9.84B | 16.99 | ― | 0.99% | 4.05% | 21.98% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥9.34B | 18.69 | ― | 2.74% | 8.14% | 14.87% | |
49 Neutral | ¥10.60B | 10.58 | ― | 2.33% | -4.56% | -54.63% | |
49 Neutral | ¥11.73B | 9.66 | ― | 3.97% | -7.53% | -49.94% |